Sherin S. Abdel-Meguid

Dr. Abdel-Meguid has extensive experience in drug discovery. From 2000 to 2004, he was Chief Scientific Officer and Co-Founder of Suntory Pharmaceutical Research Laboratories (SPRL), a company dedicated to the development of drugs for the treatment of cardiovascular and immune disorders. Prior to SPRL, he was Transnational Director of Structural Biology and Director of Macromolecular Sciences at SmithKline Beecham (SB), now Glaxo SmithKline (GSK).

He joined SB from Monsanto where he was head of Biophysical Sciences and Protein Engineering. Dr. Abdel-Meguid obtained his Ph.D. in chemistry from the University of Nebraska and postdoctoral training from Purdue and Yale Universities. He is the author of over 100 papers and was named inventor on 7 issued US patents.